Dr. Robert C. Smith, MD

Dr. Smith practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Smith's NPI, 1316922784, was assigned on December 8, 2005. Dr. Smith graduated from Vagelos College of Physicians and Surgeons in 1989. Dr. Smith holds New Jersey license MA067639.

Dr. Smith's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Smith's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Smith is also affiliated with Riverview Medical Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Smith to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Smith is board certified in urology by the American Board of Urology. Dmand AI has Dr. Smith's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer and prostate surgery among the conditions Dr. Smith treats.

CMS data shows 1,225 Medicare services from Dr. Smith across 15 procedure codes in 2024, for 614 Medicare patients. Medicare paid $94,510 for them. Every service was in an office.

CMS counts 614 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 278 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 73, with 15% women.

In 2024, Dr. Smith wrote 177 Medicare Part D claims for 79 patients. 93% of them were for generic drugs. CMS names the drug for 99 of them, across 3 drugs with 11 or more claims each, at $789 in total drug cost. In 2023, CMS named 145 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Smith for performance year 2024, reported as part of a group. Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Smith, published from 2021 to 2024. 2024 was the busiest year, with 2. Dr. Smith's most frequent co-authors are Eugene K. Cha, MD, Timothy Francis Donahue, MD and Behfar Ehdaie, MD.

CMS Open Payments shows 87 general payments to Dr. Smith from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Merck Sharp & Dohme Corporation paid the most, $6,268.

Dmand AI lists 2 awards for Dr. Smith, most recently ACS Fellow in 2012.

Dr. Smith graduated from Vagelos College of Physicians and Surgeons in 1989. Dr. Smith is a member of ACS and AUA.

Dr. Smith is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.